ArticleInternal medicine (Tokyo, Japan)2021

Impact of Pemafibrate in Patients with Hypertriglyceridemia and Metabolic Dysfunction-associated Fatty Liver Disease Pathologically Diagnosed with Non-alcoholic Steatohepatitis: A Retrospective, Single-arm Study.

Takeshi Hatanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.